Yale scientists give the Golgi apparatus its own identity, paving the way for more targeted cancer research

November 13, 2000

Researchers at Yale have discovered that, contrary to previous beliefs, the Golgi apparatus is an organelle that exists independently of the larger endoplasmic reticulum and is a crucial component of cell division.

Published in a recent issue of Nature, the discovery gives researchers a better understanding of the cell division process and of the processes present in the uncontrolled cell division that marks cancer.

In normal cell division, a mother cell divides into two daughters and the division is regulated until it stops. In a skin melanoma, for example, the cell division inexplicably starts up again and continues unregulated. This study could help cancer researchers understand why the regulation stops.

"Researchers once thought that the Golgi apparatus was no more than an outgrowth of an organelle called the endoplasmic reticulum," said Graham Warren, professor of cell biology at Yale and a leading expert in the field. "We've shown that it is an organelle within a cell that has its own autonomy and so must grow and divide to keep pace with the growth and division of the cell it inhabits."

The Golgi apparatus sorts and modifies cell products such as hormones, growth factors and digestive enzymes, and sends them to their final destinations within the cell. For example, the Golgi decides whether a given protein will leave the cell or be delivered to the cell surface or another destination. As with all other cellular organelles, the Golgi has to grow and divide and has to be inherited.

The Golgi apparatus is normally thought of as a stack of membrane compartments through which the secretory proteins pass, but Warren and colleagues have been able to show that the Golgi has an existence even when these membranes are removed from the apparatus.

"We found that there are proteins, which we term matrix proteins, that form a scaffold to organize the membranes," said Warren. "We think this scaffold might be the Golgi apparatus proper, responsible for its growth, division and partitioning between the two daughter cells."

In past research, Warren and his team have shown that the regrowth of a mother Golgi in the newly formed daughter cells requires a number of matrix proteins that are involved in putting the new Golgi complex together.

The significance of this new finding, Warren said, is at the basic cell biological level. "People have tended to think of organelles such as the Golgi in terms of the membranes, in part because this is the structure you see by electron microscopy," said Warren. "You don't see the matrix proteins. What we have done is to focus attention on these underlying structures, which might actually be more relevant to people interested in studying the biogenesis of these organelles."

Warren said his research brings together a broad spectrum of scientific disciplines, including traditional cell biology, biochemistry, molecular biology and structural biology.

"Now that we know that the Golgi is an independent organelle that has its own identity, we can start looking at it from a basic cell biology perspective that has medical implications for diseases like cancer, " said Warren.
-end-
Warren's research team included Joachim Seemann and Marc Pypaert at Yale and Eija Jokitalo from the Institute of Biotechnology in Helsinki, Finland.

Yale University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.